Navigation Links
Faculty of 1000 introduces a unique opinion-based journal metric
Date:10/5/2011

Based on the expert opinion of over 10,000 internationally renowned scientists and clinicians, the F1000 Journal Factor (FFj) is a new way of looking at the research literature. A measure of how scientists actually rate journals, the FFj is derived from our familiar rating system of articles, where named F1000 members score research articles as 'Recommended', 'Must Read' or 'Exceptional'. We now use these to generate a score for each journal that has had research articles evaluated by F1000.

The F1000 Journal Rankings enable researchers to see where the best research is being published, as judged by the F1000 Faculty. In general, the more papers that get selected by our Faculty, the higher will be that journal's FFj. Specialist journals with a low volume overall but a high proportion of research articles evaluated in F1000 will do particularly well.

Journals are ranked across all disciplines, but also within each F1000 Faculty and Section. Individual journals may be ranked relatively low overall but come out on top within a Section, showcasing their importance within a specialized field. This enables researchers to find out which journals have the most evaluated papers in their own specialty.

Each month F1000 will publish 'current' rankings based on evaluations of research papers received in the previous 12 months. Each year we will make available historical rankings, based on a calendar year's worth of articles, for easy comparison with the Journal Impact Factor. These will take into account F1000 evaluations received during that year, and up to six ('provisional') or eighteen ('final') months after the end of the year.

The FFj is:

Qualitativecalculated based on the opinions of active scientists and clinicians, experts in their fields. This avoids inherent problems with assessing journals based on citations or download metrics.

Transparentwe make it easy to see exactly which articles count towards a jour
'/>"/>

Contact: Eleanor Howell
press@f1000.com
44-207-631-9129
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen
3. Eight ASU faculty elected as AAAS Fellows
4. 13 UCR faculty members recognized by American Association for the Advancement of Science
5. UT faculty members win American Heart Association awards for advancing research
6. Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant
7. 6 young ASU faculty earn NSF Career awards
8. Women faring well in hiring process for science faculty jobs at research universities
9. Faculty of Translational Medicine boosts support for biomedical researchers
10. Faculty of 1000 praised by Wellcome Trust
11. Iowa State faculty attract $4.8 million in American Recovery and Reinvestment Act grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... of Medicine reports positive results of a phase ... subset of lung cancer marked by rearrangement of the ... with advanced non-small cell lung cancer testing positive for ... with 3 complete responses and 33 partial responses. Median ... disease to resume its growth after being slowed by ...
(Date:9/30/2014)... (LMU) in Munich report that a new class ... to chemotherapeutic drugs. They have also pinpointed the ... for anti-tumor agents. , Researchers led by ... of the Technische Universitt Mnchen have identified a ... weapon in the fight against malignant tumors. The ...
(Date:9/30/2014)... of perilous threats in today,s ocean. From overfishing ... fragile coral ecosystems are disappearing at unprecedented rates ... of corals surrounding the island of Moorea in ... tropical environment: coral guard-crabs. New research from the ... scientist Seabird McKeon and the museum,s predoctoral fellow ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
... Smart Search & Match,the leading provider of high-performance ... has joined the company as Product Marketing Manager. ... 15 years of product and marketing management,experience to ... many high-tech products and solutions worldwide. He has ...
... the human body in ways never imagined only a ... population of patients who are newly susceptible to opportunistic ... formidable clinical opponent, and foremost among them is ... from ASM Press. "This volume has been ...
... of the global population living in cities reached 50 ... exciting new book series which brings together leading experts ... all over the world. The aim of the ... facing the architects, planners, developers and inhabitants of the ...
Cached Biology News:New text focuses on formidable opportunistic fungus 2Springer looks ahead to the Future City 2
(Date:10/1/2014)... , October 1, 2014 ... software invited to engage around the theme, ,Commercial Opportunities ...   Elsevier , a ... and services, will host a gathering of some of ... and trends impacting healthcare today and in the future. ...
(Date:9/30/2014)... Applying a well-known optical phenomenon called thin-film interference, ... demonstrated the ability to "paint" ultra-thin coatings onto ... for making future, flexible electronic devices, creating advanced ... rocket ships and spacecraft with extremely lightweight decorative ... water, it becomes iridescent, revealing a myriad of ...
(Date:9/30/2014)... of one of nature,s most efficient light-harvesting structures, ... by Alejandro Briseno of the University of Massachusetts ... long-sought polymer architecture to boost power-conversion efficiency of ... , Briseno, with colleagues and graduate students ... and Dresden University of Technology, Germany, report in ...
(Date:9/30/2014)... Report Details Biosimilar drugs – ... Do you want to find sales potentials of ... for those biological drugs from 2014, helping you ... data, R&D trends, opportunities and selling prospects. In ... 2024 at overall world market, therapeutic class, molecule ...
Breaking Biology Technology:Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Taking thin films to the extreme 2Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... scientists observe a reaction moving at greater than 10 meters ... feat some would say is nearly impossible. But ... dynamic transmission electron microscope (DTEM). DTEM,s ability to ... it,s happening has earned it one of the 10 winning ...
... , Aug. 2 Octapharma USA today ... is the Rush Hemophilia & Thrombophilia Center at Rush ... focused on human protein therapies in hematology, immune therapy, intensive care and emergency ... Leonard A. ...
... Aug. 2 Tengion Inc. (Nasdaq: TNGN ... to the position of Chief Financial Officer.  Mr. Davis comes to Tengion ... technologies to develop improved protein therapeutics. At its peak, Neose employed 200 ... , , ...
Cached Biology Technology:Livermore's DTEM earns innovation award from Microscopy Today 2Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 2Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 3Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 4Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 5Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 6Tengion Appoints A. Brian Davis Chief Financial Officer 2
Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Polyclonal Antibody to PRG3...
Biology Products: